Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Drug Resistance

Free Subscription Articles published in J Infect Dis Retrieve available abstracts of 89 articles: HTML format

Single Articles

November 2025
1. TANG X, Ying J, Shen Y, Song X, et al
   Prevalence and Molecular Mechanisms of Amoxicillin Resistance Among Clinical Helicobacter pylori Isolates in Southwest China.
   J Infect Dis. 2025;232.
   PubMed     Abstract available
   
   
   
2. ZHANG J, Wang Y, Chen L, Zhang Q, et al
   Antimicrobial Resistance of Helicobacter pylori Among Chinese Yi Population.
   J Infect Dis. 2025;232.
   PubMed     Abstract available
   
   
   
3. TANG X, Shen Y, Song X, He B, et al
   Comparative Evaluation of Modified Agar Dilution and Standard Agar Dilution Methods for Antimicrobial Susceptibility Testing of Helicobacter pylori.
   J Infect Dis. 2025;232.
   PubMed     Abstract available
   
   
   
4. LIANG C, Zhou Y, Li Y, Xu M, et al
   Follow-up and Analysis of Helicobacter pylori Antibioic Resistance in the South Area of Sichuan Province.
   J Infect Dis. 2025;232.
   PubMed     Abstract available
   
   
   
5. ZHOU JP, Yang TK, Li J, Tay A, et al
   Rifabutin-Containing Therapy for Helicobacter pylori Eradication: A Review.
   J Infect Dis. 2025;232.
   PubMed     Abstract available
   
   
   
6. ZHANG Y, Liu K, Song X, Shen Y, et al
   Antimicrobial Resistance Patterns of Clinical Helicobacter pylori Isolates From Gastric Cancer Patients.
   J Infect Dis. 2025;232.
   PubMed     Abstract available
   
   
   
7. PODKOWIK M, Tillman A, Takats C, Carion H, et al
   CRISPR-Cas-associated SCCmec variants in methicillin-resistant Staphylococcus aureus evade rapid diagnostic detection.
   J Infect Dis. 2025 Nov 19:jiaf575. doi: 10.1093.
   PubMed     Abstract available
   
   
   
8. LENZ S, Biswas S, Terry I, Tran-Basha L, et al
   Detection of Carbapenem-Resistant Bacteria in Skilled Nursing Facility Wastewater.
   J Infect Dis. 2025 Nov 18:jiaf534. doi: 10.1093.
   PubMed     Abstract available
   
   
   
9. ARUN B, Liu E, Valle Q, Sharma R, et al
   Ampicillin/Sulbactam in Combination with Ceftazidime/Avibactam against Metallo-beta-Lactamase-Producing Carbapenem-Resistant Acinetobacter baumannii: A Genomics-Informed Mechanism-Based Model.
   J Infect Dis. 2025 Nov 12:jiaf567. doi: 10.1093.
   PubMed     Abstract available
   
   
   
10. JIANG JH, Lim CX, Lai X, Kostoulias X, et al
    Daptomycin-Loaded Nanocarriers Facilitate Synergistic Killing of Methicillin-Resistant Staphylococcus aureus via Lipid-Mediated Interactions and Targeting.
    J Infect Dis. 2025 Nov 4:jiaf492. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2025
11. LI J, Jin Y, Wang Y, Shang L, et al
    New Developments in Influenza Polymerase Inhibitors.
    J Infect Dis. 2025;232.
    PubMed     Abstract available
    
    
    
12. PASCO R, Hayden FG, Meyers LA
    Modeling Influenza Antiviral Strategies: Reducing Burden and Preventing Resistance.
    J Infect Dis. 2025;232.
    PubMed     Abstract available
    
    
    
13. HELDMAN MR, Boeckh MJ, Ison MG
    Influenza Antivirals for Prevention and Treatment in Immunocompromised People.
    J Infect Dis. 2025;232.
    PubMed     Abstract available
    
    
    
14. TAKASHITA E, Wolfe CR, Jones JC
    Laboratory Methods for Monitoring Influenza Antiviral Resistance.
    J Infect Dis. 2025;232.
    PubMed     Abstract available
    
    
    September 2025
15. PORETSKY RS, Gonzalez DS, Horton A, Schoeny M, et al
    Establishing a Practical Approach to Sewer Monitoring for Antimicrobial Resistance Genes and Organisms at Healthcare Facilities.
    J Infect Dis. 2025 Sep 24:jiaf434. doi: 10.1093.
    PubMed     Abstract available
    
    
    
16. SRIDHAR S, Worby CJ, Bronson RA, Turbett SE, et al
    Insights Into Global Antimicrobial Resistance Dynamics Through the Sequencing of Enteric Bacteria From US International Travelers.
    J Infect Dis. 2025 Sep 24:jiaf469. doi: 10.1093.
    PubMed     Abstract available
    
    
    
17. CARR MA, Chou SR, Sun J, LaRock DL, et al
    Therapeutic Inhibition of Metalloproteases by Tetracyclines During Infection by Multidrug-Resistant Pseudomonas.
    J Infect Dis. 2025;232:e416-e420.
    PubMed     Abstract available
    
    
    
18. GONTJES KJ, Singh A, Sansom SE, Boyko JD, et al
    Phylogenetic context of antibiotic resistance provides insights into the dynamics of resistance emergence and spread.
    J Infect Dis. 2025 Sep 15:jiaf478. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2025
19. ROBERTS M, Davis P
    Doxycycline post-exposure prophylaxis and off-target antimicrobial resistance: potential amplification within sexual networks.
    J Infect Dis. 2025 Aug 20:jiaf439. doi: 10.1093.
    PubMed     Abstract available
    
    
    
20. WATKINS RR, Lemonovich TL, Vila AJ, Bonomo RA, et al
    Cefepime-Taniborbactam-a Novel Combination Therapy for Multidrug-Resistant Pathogens.
    J Infect Dis. 2025;232:278-284.
    PubMed     Abstract available
    
    
    
21. CHOUDHURY NR, Urwin L, Salamaga B, Prince LR, et al
    Determining the importance of the stringent response for methicillin-resistant Staphylococcus aureus virulence in vivo.
    J Infect Dis. 2025 Aug 8:jiaf421. doi: 10.1093.
    PubMed     Abstract available
    
    
    
22. LIAO CH, Huang YL, Ioerger T, Lim KS, et al
    Genomic and phenotypic insights into antibiotic resistance and virulence of Klebsiella pneumoniae from the environment in Southern Taiwan.
    J Infect Dis. 2025 Aug 1:jiaf396. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2025
23. MARANO RBM, Oster Y, Benenson S, Motro Y, et al
    An Omics-Guided Investigation of a Hospital Outbreak Caused by blaNDM-1-Producing Pseudocitrobacter faecalis.
    J Infect Dis. 2025;232:e17-e26.
    PubMed     Abstract available
    
    
    
24. LAUMEN JGE, Hieu VN, Nhung PH, Vandelannoote K, et al
    High Prevalence of Ceftriaxone-Resistant Neisseria gonorrhoeae in Hanoi, Vietnam, 2023-2024.
    J Infect Dis. 2025;232:e73-e77.
    PubMed     Abstract available
    
    
    
25. CAILLAULT A, Softic L, Bay P, Ly A, et al
    Molecular Characterization of Respiratory Syncytial Virus Infections in Elderly Patients During the 2023-2024 Season in the Era of Nirsevimab Introduction.
    J Infect Dis. 2025;232:199-202.
    PubMed     Abstract available
    
    
    
26. SHIMUTA K, Ohama Y, Ito S, Hoshina S, et al
    Emergence of Ceftriaxone-Resistant Neisseria gonorrhoeae Through Horizontal Gene Transfer Among Neisseria Species.
    J Infect Dis. 2025;232:152-161.
    PubMed     Abstract available
    
    
    
27. WANG TW, Putnam N, Johnson JK, Jabra-Rizk MA, et al
    In vivo evolution of Candida auris multi-drug resistance in a patient receiving antifungal treatment.
    J Infect Dis. 2025 Jul 30:jiaf394. doi: 10.1093.
    PubMed     Abstract available
    
    
    
28. TALBOT BM, Jacko NF, Hofstetter KS, Alahakoon T, et al
    Methicillin-Resistant Staphylococcus aureus Bacteremia Relapses Show Diverse Genomic Profiles but Convergence in Bacteremia-Associated Genes.
    J Infect Dis. 2025 Jul 25:jiaf352. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2025
29. NORGAARD JC, Marandi RZ, Ilett EE, Gulay A, et al
    The gut microbiome and its resistome as predictors of clinical infections and phenotypic antibiotic resistance in hematopoietic stem cell transplant recipients.
    J Infect Dis. 2025 Jun 23:jiaf330. doi: 10.1093.
    PubMed     Abstract available
    
    
    
30. DOORLEY LA, Meza-Perez V, Jones SJ, Rybak JM, et al
    A Candidozyma (Candida) auris-Optimized Episomal Plasmid-Induced Cas9-Editing System Reveals the Direct Impact of the S639F-Encoding FKS1 Mutation.
    J Infect Dis. 2025 Jun 17:jiaf285. doi: 10.1093.
    PubMed     Abstract available
    
    
    
31. BUSTION AE, Ernest JP, Kaya F, Silva C, et al
    The kinetics of bedaquiline diffusion in tuberculous cavities open a window for emergence of resistance.
    J Infect Dis. 2025 Jun 4:jiaf303. doi: 10.1093.
    PubMed     Abstract available
    
    
    
32. DESCHENES NM, Perez-Vargas J, Zhong Z, Thomas M, et al
    Functional and structural characterization of treatment-emergent nirmatrelvir resistance mutations at low frequencies in the main protease (Mpro) reveals a unique evolutionary route for SARS-CoV-2 to gain resistance.
    J Infect Dis. 2025 Jun 3:jiaf294. doi: 10.1093.
    PubMed     Abstract available
    
    
    
33. YANG T, Beach KE, Zhu C, Gan M, et al
    Genomic Analysis of Global Mycobacterium abscessus Isolates Reveals Ongoing Evolution of Drug Resistance-Associated Genes.
    J Infect Dis. 2025;231:1150-1154.
    PubMed     Abstract available
    
    
    May 2025
34. LI Y, Stellfox ME, Evans KM, Mills EG, et al
    Functional genomics of antibiotic susceptibility in Enterococcus faecalis from infective endocarditis.
    J Infect Dis. 2025 May 30:jiaf272. doi: 10.1093.
    PubMed     Abstract available
    
    
    
35. MCHUGH J, Chesdachai S, Dunsirn M, Wengenack N, et al
    Increasing Fluconazole Resistance in Candida parapsilosis: A 10-Year Analysis of Blood Culture Isolates at a US Reference Laboratory (2015-2024).
    J Infect Dis. 2025 May 13:jiaf249. doi: 10.1093.
    PubMed     Abstract available
    
    
    April 2025
36. MOGENI P, Ochieng JB, Atlas HE, Tickell KD, et al
    Impact of macrolide resistance on azithromycin for prevention of rehospitalization or death among children discharged from hospitals in Western Kenya.
    J Infect Dis. 2025 Apr 21:jiaf208. doi: 10.1093.
    PubMed     Abstract available
    
    
    
37. PARK H, Abrams JA, Uhlemann AC, Freedberg DE, et al
    Gut colonization with vancomycin-resistant Enterococcus shapes the gut microbiome in the intensive care unit.
    J Infect Dis. 2025 Apr 16:jiaf194. doi: 10.1093.
    PubMed     Abstract available
    
    
    
38. MASTERS TL, Toney NC, Ewing TO, McAllister GA, et al
    Genomic Epidemiology of Extrapulmonary Nontuberculous Mycobacteria Isolates at Emerging Infections Program Sites-United States, 2019-2020.
    J Infect Dis. 2025;231:902-912.
    PubMed     Abstract available
    
    
    March 2025
39. PARAU G, Parks HJ, Anderson AJG, Bisaro F, et al
    Clinical isolates of antimicrobial resistant Enterobacter species can persist in human macrophages without replication and overt cellular cytotoxicity.
    J Infect Dis. 2025 Mar 3:jiaf099. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2025
40. LEVENE RE, DeVincenzo J, Conery AL, Ahmad A, et al
    EDP-938 Has a High Barrier to Resistance in Healthy Adults Experimentally Infected with Respiratory Syncytial Virus.
    J Infect Dis. 2025;231:e290-e298.
    PubMed     Abstract available
    
    
    
41. GASPAR C, Rios P, Moeller TD
    Landscape of Bacterial Enteric Disease and Traveler s Diarrhea in South America.
    J Infect Dis. 2025;231.
    PubMed     Abstract available
    
    
    January 2025
42. MARGOT NA, Jogiraju V, Pennetzdorfer N, Naik V, et al
    Resistance Analyses in Heavily Treatment-Experienced People with HIV Treated with the Novel HIV Capsid Inhibitor Lenacapavir After 2 years.
    J Infect Dis. 2025 Jan 28:jiaf050. doi: 10.1093.
    PubMed     Abstract available
    
    
    
43. JANKEEL A, Perez-Parra G, Khetarpal AK, Alvarado IA, et al
    Enhanced Killing of Methicillin-Resistant Staphylococcus aureus with Ceftaroline or Vancomycin in Combination with Carbapenems.
    J Infect Dis. 2025 Jan 8:jiaf010. doi: 10.1093.
    PubMed     Abstract available
    
    
    December 2024
44. LI Y, Mishra NN, Chen L, Manna AC, et al
    Phage-Encoded Virulence Factor, Gp05, Alters Membrane Phospholipids and Reduces Antimicrobial Susceptibility in Methicillin-Resistant Staphylococcus aureus.
    J Infect Dis. 2024 Dec 31:jiae640. doi: 10.1093.
    PubMed     Abstract available
    
    
    
45. NTOZINI B, Walaza S, Metcalf B, Hazelhurst S, et al
    Molecular epidemiology of invasive group B Streptococcus in South Africa, 2019-2020.
    J Infect Dis. 2024 Dec 31:jiae633. doi: 10.1093.
    PubMed     Abstract available
    
    
    
46. MITTELSTAEDT R, Kanjilal S, Helekal D, Robbins GK, et al
    Staphylococcus aureus Tetracycline Resistance and Co-resistance in a Doxy-PEP-Eligible Population.
    J Infect Dis. 2024 Dec 24:jiae634. doi: 10.1093.
    PubMed    
    
    
    
47. MIKHARI RL, Meiring S, de Gouveia L, Chan WY, et al
    Genomic Diversity and Antimicrobial Susceptibility of Invasive Neisseria meningitidis in South Africa, 2016-2021.
    J Infect Dis. 2024;230:e1311-e1321.
    PubMed     Abstract available
    
    
    November 2024
48. JACQUELINE C, Minetti C, Monzon Fernandez S, Silveira L, et al
    Genomic epidemiology of fluoroquinolone-resistant strains of Shigella sonnei and Shigella flexneri in the Iberian Peninsula from 2015 to 2022.
    J Infect Dis. 2024 Nov 29:jiae596. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2024
49. MACLEAN AKW, Morrow S, Niu F, Hanson ND, et al
    What Contributes to the Minimum Inhibitory Concentration? Beyond beta-Lactamase Gene Detection in Klebsiella pneumoniae.
    J Infect Dis. 2024;230:e777-e788.
    PubMed     Abstract available
    
    
    
50. SANSOM SE, Shimasaki T, Dangana T, Lin MY, et al
    Comparison of Daily Versus Admission and Discharge Surveillance Cultures for Multidrug-Resistant Organism Detection in an Intensive Care Unit.
    J Infect Dis. 2024;230:807-815.
    PubMed     Abstract available
    
    
    
51. RAJAGOPALAN S, Rourke AK, Asare E, Kohlerschmidt DJ, et al
    Engineered Mycobacteriophage TM4::GeNL Rapidly Determines Bedaquiline, Pretomanid, Linezolid, Rifampicin, and Clofazimine Sensitivity in Mycobacterium tuberculosis Clinical Isolates.
    J Infect Dis. 2024 Oct 16:jiae438. doi: 10.1093.
    PubMed     Abstract available
    
    
    
52. GAWOR J, Zuchniewicz K, Ojeda Saavedra M, Beres SB, et al
    ICESp1109, a novel hybrid Integrative Conjugative Element of macrolide-resistant Streptococcus pyogenes serotype M77 collected between 2003 and 2017 in Poland.
    J Infect Dis. 2024 Oct 12:jiae473. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2024
53. CHOU S, Winston DJ, Avery RK, Cordonnier C, et al
    Comparative Emergence of Maribavir and Ganciclovir Resistance in a Randomized Phase 3 Clinical Trial for Treatment of Cytomegalovirus Infection.
    J Infect Dis. 2024 Sep 20:jiae469. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2024
54. NAGELE K, Battig V, Gosert R, Walti CS, et al
    Revealing the unseen: next generation sequencing for early detection of drug-resistant cytomegalovirus variants upon letermovir prophylaxis failure.
    J Infect Dis. 2024 Aug 30:jiae414. doi: 10.1093.
    PubMed     Abstract available
    
    
    
55. YE J, Dong Y, Lan Y, Chen J, et al
    Trends and Patterns of HIV Transmitted Drug Resistance in China From 2018 to 2023.
    J Infect Dis. 2024 Aug 27:jiae303. doi: 10.1093.
    PubMed     Abstract available
    
    
    
56. YEK C, Lon C, Chea S, Lay S, et al
    Bacterial Genomics for National Antimicrobial Resistance Surveillance in Cambodia.
    J Infect Dis. 2024 Aug 20:jiae417. doi: 10.1093.
    PubMed     Abstract available
    
    
    
57. CHOUDHARY MC, Deo R, Evering TH, Chew KW, et al
    Characterization of Treatment Resistance and Viral Kinetics in the Setting of Single-Active Versus Dual-Active Monoclonal Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2.
    J Infect Dis. 2024;230:394-402.
    PubMed     Abstract available
    
    
    
58. CHOCHUA S, Beall B, Lin W, Tran T, et al
    The emergent invasive serotype 4 ST10172 strain acquires vanG type vancomycin-resistance element: A case of a 66-year-old with bacteremic pneumococcal pneumonia.
    J Infect Dis. 2024 Aug 8:jiae393. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2024
59. TANTALO LC, Luetkemeyer A, Lieberman NAP, Nunley BE, et al
    Long-term in vitro exposure of Treponema pallidum to sub-bactericidal doxycycline did not induce resistance: Implications for doxy-PEP and syphilis.
    J Infect Dis. 2024 Jul 27:jiae381. doi: 10.1093.
    PubMed     Abstract available
    
    
    
60. BURDORF RM, Zhou S, Amon C, Long N, et al
    Impact of Low-Frequency Human Immunodeficiency Virus Type 1 Drug Resistance Mutations on Antiretroviral Therapy Outcomes.
    J Infect Dis. 2024;230:86-94.
    PubMed     Abstract available
    
    
    
61. GUITOR AK, Katyukhina A, Mokomane M, Lechiile K, et al
    Minimal Impact on the Resistome of Children in Botswana After Azithromycin Treatment for Acute Severe Diarrheal Disease.
    J Infect Dis. 2024;230:239-249.
    PubMed     Abstract available
    
    
    
62. HENRY SA, Webster CM, Shaw LN, Torres NJ, et al
    Steroid Drugs Inhibit Bacterial Respiratory Oxidases and Are Lethal Toward Methicillin-Resistant Staphylococcus aureus.
    J Infect Dis. 2024;230:e149-e158.
    PubMed     Abstract available
    
    
    
63. AUNG S, Novitsky V, Steingrimsson J, Gillani FS, et al
    Acquired Human Immunodeficiency Virus Type 1 Drug Resistance in Rhode Island, USA, 2004-2021.
    J Infect Dis. 2024 Jul 23:jiae344. doi: 10.1093.
    PubMed     Abstract available
    
    
    
64. BLECHMAN SE, Wright ES
    Applications of machine learning on electronic health record data to combat antibiotic resistance.
    J Infect Dis. 2024 Jul 12:jiae348. doi: 10.1093.
    PubMed     Abstract available
    
    
    
65. ZHOU S, Long N, Rosenke K, Jarvis MA, et al
    Combined Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 Reduces Molnupiravir-Induced Mutagenicity and Prevents Selection for Nirmatrelvir/Ritonavir Resistance Mutations.
    J Infect Dis. 2024 Jul 8:jiae213. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2024
66. CHOW EPF, Stevens K, De Petra V, Chen MY, et al
    Prevalence of cefixime-resistant Neisseria gonorrhoeae in Melbourne, Australia, 2021-2022.
    J Infect Dis. 2024 Jun 15:jiae313. doi: 10.1093.
    PubMed     Abstract available
    
    
    
67. SOKAL A, Royer G, Esposito-Farese M, Clermont O, et al
    Clinical and Bacteriological Specificities of Escherichia coli Bloodstream Infections From Biliary Portal of Entries.
    J Infect Dis. 2024;229:1679-1687.
    PubMed     Abstract available
    
    
    
68. DAI T, Ma C, Zhang F, Wang H, et al
    The Efficacy and Safety of an Intra-articular Dual-Acting Antibacterial Agent (TNP-2092) for Implant Infection-Associated Methicillin-Resistant Staphylococcus aureus.
    J Infect Dis. 2024;229:1658-1668.
    PubMed     Abstract available
    
    
    
69. STRIZKI JM, Diamond TL, Teal VL, Gilbert CL, et al
    Cytomegalovirus antiviral resistance among participants in the phase 3 trial of letermovir vs valganciclovir prophylaxis in kidney transplant recipients.
    J Infect Dis. 2024 Jun 10:jiae287. doi: 10.1093.
    PubMed     Abstract available
    
    
    May 2024
70. DIXIT A, Ektefaie Y, Kagal A, Freschi L, et al
    Drug resistance and epidemiological success of modern Mycobacterium tuberculosis lineages in western India.
    J Infect Dis. 2024 May 31:jiae240. doi: 10.1093.
    PubMed     Abstract available
    
    
    
71. MCCLUSKEY SM, Muyindike WR, Nanfuka V, Omoding D, et al
    Population Effectiveness of Dolutegravir Implementation in Uganda - A Prospective Observational Cohort Study (DISCO): 48-week Results.
    J Infect Dis. 2024 May 16:jiae260. doi: 10.1093.
    PubMed     Abstract available
    
    
    
72. TAGAMI Y, Horita N, Kaneko M, Muraoka S, et al
    Whole-Genome Sequencing Predicting Phenotypic Antitubercular Drug Resistance: Meta-analysis.
    J Infect Dis. 2024;229:1481-1492.
    PubMed     Abstract available
    
    
    
73. KU JH, Tartof SY, Contreras R, Ackerson BK, et al
    Antibiotic resistance of urinary tract infection recurrences in a large U.S. integrated health care system.
    J Infect Dis. 2024 May 14:jiae233. doi: 10.1093.
    PubMed     Abstract available
    
    
    
74. COSTA C, Sirard JC, Gibson PS, Veening JW, et al
    Triggering Toll-Like Receptor 5 signaling during pneumococcal superinfection prevents the selection of antibiotic resistance.
    J Infect Dis. 2024 May 8:jiae239. doi: 10.1093.
    PubMed     Abstract available
    
    
    April 2024
75. MILLER WR, Nguyen A, Singh KV, Rizvi S, et al
    Membrane Lipids Augment Cell Envelope Stress Signaling via the MadRS System to Defend Against Antimicrobial Peptides and Antibiotics in Enterococcus faecalis.
    J Infect Dis. 2024 Apr 5:jiae173. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2024
76. BROUGH SC, Caddell L, Liou RJ, Patil A, et al
    Predicting Increased Incidence of Common Antibiotic-Resistant and Antibiotic-Associated Pathogens Using Ensemble Species Distribution Modeling.
    J Infect Dis. 2024 Mar 27:jiae145. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2024
77. PENG KT, Chen PC, Chen JL, Huang TY, et al
    A comparative phenotypic and genomic analysis of methicillin-resistant Staphylococcus aureus ST45 isolates from cellulitis and from osteomyelitis in Taiwan.
    J Infect Dis. 2024 Feb 26:jiae096. doi: 10.1093.
    PubMed     Abstract available
    
    
    
78. SAUVE K, Watson A, Oh JT, Swift S, et al
    The Engineered Lysin, CF-370, is Active Against Antibiotic-Resistant Gram-Negative Pathogens In vitro and Synergizes with Meropenem in Experimental Pseudomonas aeruginosa Pneumonia.
    J Infect Dis. 2024 Feb 15:jiae027. doi: 10.1093.
    PubMed     Abstract available
    
    
    
79. HENRY SA, Webster CM, Shaw LN, Torres NJ, et al
    Steroid Drugs Inhibit Bacterial Respiratory Oxidases and Are Lethal Toward Methicillin-Resistant Staphylococcus aureus.
    J Infect Dis. 2024 Feb 13:jiad540. doi: 10.1093.
    PubMed     Abstract available
    
    
    January 2024
80. XIONG YQ, Li Y, Goncheva MI, Elsayed AM, et al
    The Purine Biosynthesis Repressor, PurR, Contributes to Vancomycin Susceptibility of Methicillin-resistant Staphylococcus aureus in Experimental Endocarditis.
    J Infect Dis. 2024 Jan 31:jiad577. doi: 10.1093.
    PubMed     Abstract available
    
    
    
81. GIAMMARINO F, de Salazar A, Malet I, Vinuela L, et al
    Prevalence and phenotypic susceptibility to doravirine of the HIV-1 reverse transcriptase V106I polymorphism in B and non-B subtypes.
    J Infect Dis. 2024 Jan 11:jiae010. doi: 10.1093.
    PubMed     Abstract available
    
    
    
82. VENTURINI C, Colston JM, Charles O, Lankina A, et al
    Persistent low-level variants in a subset of viral genes are highly predictive of poor outcome in immunocompromised patients with cytomegalovirus infection.
    J Infect Dis. 2024 Jan 5:jiae001. doi: 10.1093.
    PubMed     Abstract available
    
    
    December 2023
83. SMITH RA, Raugi DN, Nixon RS, Seydi M, et al
    Antiviral Activity of Lenacapavir Against HIV-2 Isolates and Drug-resistant HIV-2 Mutants.
    J Infect Dis. 2023 Dec 7:jiad562. doi: 10.1093.
    PubMed     Abstract available
    
    
    November 2023
84. PHILLIPS LT, Witney AA, Furegato M, Laing KG, et al
    Time Required for Nanopore Whole-Genome Sequencing of Neisseria gonorrhoeae for Identification of Phylogenetic Relationships.
    J Infect Dis. 2023;228:1179-1188.
    PubMed     Abstract available
    
    
    September 2023
85. ANDREEV K, Jones JC, Seiler P, Kandeil A, et al
    Antiviral Susceptibility of Highly Pathogenic Avian Influenza A(H5N1) Viruses Circulating Globally in 2022-2023.
    J Infect Dis. 2023 Sep 28:jiad418. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2023
86. CHOU S, Alain S, Cervera C, Chemaly RF, et al
    Drug Resistance Assessed in a Phase 3 Clinical Trial of Maribavir Therapy for Refractory or Resistant Cytomegalovirus Infection in Transplant Recipients.
    J Infect Dis. 2023 Jul 28:jiad293. doi: 10.1093.
    PubMed     Abstract available
    
    
    
87. HU Z, Cordwell T, Nguyen H, Li J, et al
    Effect of the L74I Polymorphism on Fitness of Cabotegravir-Resistant Variants of HIV-1 Subtype A6.
    J Infect Dis. 2023 Jul 27:jiad291. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2023
88. SINGH DK, Bhaskar A, Pahuja I, Shaji A, et al
    Co-treatment with Clofazimine and Rapamycin eliminates drug-resistant tuberculosis by inducing polyfunctional central memory T cell responses.
    J Infect Dis. 2023 Jun 8:jiad214. doi: 10.1093.
    PubMed     Abstract available
    
    
    May 2023
89. SCHALKWIJK HH, Georgala A, Gillemot S, Temblador A, et al
    A Herpes Simplex virus 1 DNA Polymerase Multidrug Resistance Mutation Identified in an Immunocompromised Patient - Confirmed by Gene Editing.
    J Infect Dis. 2023 May 24:jiad184. doi: 10.1093.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Drug Resistance is free of charge.